MedTrace Logo

Esthesioneuroblastoma: Outcomes After Treatment

NCT02580136 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-02-11

No results posted yet for this study

Summary

The purpose of this study is to collect and organize data into a repository to gather relevant information for future research from patients diagnosed with a rare malignant sinonasal cancer called esthesioneuroblastoma (ENB) and are scheduled to undergo endonasal skull base surgery. Data being collected includes surgical data, demographics, disease presentation, MRI, CT, PET imaging, and post-operative assessments including pathology tests. After surgery, the investigators will collect chemotherapy and radiation data. Participants will also complete quality of life questionnaires at their follow-up visits.

Conditions

  • Esthesioneuroblastoma, Olfactory

Sponsors & Collaborators

  • Ricardo L. Carrau, MD

    lead OTHER

Principal Investigators

  • Ricardo Carrau, MD · Ohio State University

Eligibility

Min Age
10 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2021-02-08
Completion
2021-02-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02580136 on ClinicalTrials.gov